These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8702503)

  • 1. Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15.
    Phelps RG; Turner AN; Rees AJ
    J Biol Chem; 1996 Aug; 271(31):18549-53. PubMed ID: 8702503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
    Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
    J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
    Phelps RG; Jones V; Turner AN; Rees AJ
    Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.
    Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN
    J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen.
    Huynh M; Eggenhuizen PJ; Olson GL; Rao NB; Self CR; Sun Y; Holdsworth SR; Kitching AR; Ooi JD
    J Autoimmun; 2019 Sep; 103():102276. PubMed ID: 31104947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes.
    Zou J; Henderson L; Thomas V; Swan P; Turner AN; Phelps RG
    J Am Soc Nephrol; 2007 Mar; 18(3):771-9. PubMed ID: 17287425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
    Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
    J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy individuals have Goodpasture autoantigen-reactive T cells.
    Zou J; Hannier S; Cairns LS; Barker RN; Rees AJ; Turner AN; Phelps RG
    J Am Soc Nephrol; 2008 Feb; 19(2):396-404. PubMed ID: 18216317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
    Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
    Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
    Kalluri R; Sun MJ; Hudson BG; Neilson EG
    J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
    Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
    Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ; Mason PJ; Pusey CD; Turner N
    Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
    Netzer KO; Leinonen A; Boutaud A; Borza DB; Todd P; Gunwar S; Langeveld JP; Hudson BG
    J Biol Chem; 1999 Apr; 274(16):11267-74. PubMed ID: 10196215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
    Ooi JD; Petersen J; Tan YH; Huynh M; Willett ZJ; Ramarathinam SH; Eggenhuizen PJ; Loh KL; Watson KA; Gan PY; Alikhan MA; Dudek NL; Handel A; Hudson BG; Fugger L; Power DA; Holt SG; Coates PT; Gregersen JW; Purcell AW; Holdsworth SR; La Gruta NL; Reid HH; Rossjohn J; Kitching AR
    Nature; 2017 May; 545(7653):243-247. PubMed ID: 28467828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis.
    Ryan JJ; Reynolds J; Norgan VA; Pusey CD
    Nephrol Dial Transplant; 2001 Feb; 16(2):253-61. PubMed ID: 11158397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.
    Xie LJ; Cui Z; Chen FJ; Pei ZY; Hu SY; Gu QH; Jia XY; Zhu L; Zhou XJ; Zhang H; Liao YH; Lai LH; Hudson BG; Zhao MH
    Immunology; 2017 Aug; 151(4):395-404. PubMed ID: 28342268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
    Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
    J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune recognition of glomerular antigens.
    Phelps RG
    Exp Nephrol; 2000; 8(4-5):226-34. PubMed ID: 10940721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
    Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
    Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis.
    Robertson J; Wu J; Arends J; Glass W; Southwood S; Sette A; Lou YH
    Kidney Int; 2005 Sep; 68(3):1061-70. PubMed ID: 16105036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.